Screener
Perspective Therapeutics CATX Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Perspective Therapeutics’s reported figures.
Based on trailing twelve months.
The source filing: Perspective Therapeutics’s 10-Q, filed August 10, 2026. Open the filing →
- Filed
- Aug 10, 2026, 4:34 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-342512
FAQ
- What is Perspective Therapeutics's return on equity?
- Perspective Therapeutics (CATX) reported return on equity of -39.5% in Q2 2026.
- How has Perspective Therapeutics's return on equity changed year-over-year?
- Perspective Therapeutics's return on equity decreased by 26.2% year-over-year, from -31.3% to -39.5%.
- What is the long-term trend for Perspective Therapeutics's return on equity?
- Over 5 years (2020 to 2025), Perspective Therapeutics's return on equity has grown at a 3.4% compound annual growth rate (CAGR), from -35% to -41.4%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.
Ask your AI about Perspective Therapeutics's return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude